Back

Long-term Outcomes of the DanGer Shock Trial

31 August 2025 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Late Breaking Clinical Science: optimal management of cardiogenic shock Shock ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jacob Eifer Moller

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
Age Analysis of the MCS in CS Meta Analysis
Professor U. Zeymer (Ludwigshafen, DE)
Slides Video
Presentation thumbnail
Centralization of CS care and MCS use
Doctor B. Schrage (Hamburg, DE)
Slides Video
Presentation thumbnail
The REBOARREST Trial, a randomized controlled trial on aortic occlusion during cardiac arrest
Doctor J. Brede (Trondheim, NO)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Science: optimal management of cardiogenic shock
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial
thumbnail
Congress Presentation
Effect of microaxial flow pump on hemodynamics in infarct-related cardiogenic shock
thumbnail
Congress Presentation
The influence of treatment delay on the benefit of a microaxial flow pump in patients with ST segment elevation myocardial infarction and cardiogenic shock

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources